Melatonin Neurim

Melatonin, the active ingredient in Melatonin Neurim, is a melatonin receptor agonist presented as a tablet (strength not specified) for oral use. It helps regulate the sleep‑wake cycle and is used to manage insomnia, other sleep disorders, and jet lag in adults.

GNH USA supplies Melatonin Neurim as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melatonin Neurim works by activating melatonin receptors to support normal sleep regulation.

- Insomnia: reduces the time needed to fall asleep and may improve sleep continuity. - Sleep disorders: enhances overall sleep quality and duration in various sleep‑related conditions. - Jet lag: assists the body in adjusting its circadian rhythm after rapid travel across time zones.

Melatonin Neurim is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Drowsiness or daytime sleepiness - Headache - Dizziness - Nausea or mild gastrointestinal discomfort - Vivid dreams or unusual nocturnal imagery - Mild fatigue

Serious or Rare Side Effects: - Allergic reactions such as rash, itching, or swelling - Severe dizziness or vertigo - Mood changes including depression or anxiety - Abnormal heart rhythm (rare) - Hallucinations or psychotic symptoms (very rare)

Before using Melatonin Neurim, consider the following safety measures. - Assess sleep patterns: evaluate underlying causes of insomnia before initiating therapy. - Driving and operating machinery: avoid activities requiring alertness if drowsiness occurs. - Concomitant CNS depressants: use with caution when combined with other sedatives. - Pregnancy and breastfeeding: consult a healthcare professional before use. - Pediatric use: not recommended for children without medical supervision. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Melatonin Neurim may interact with other medications; monitoring is advised.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Immunosuppressants (e.g., cyclosporine): reduced melatonin efficacy. - Central nervous system depressants (e.g., benzodiazepines): additive sedation.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may raise melatonin plasma levels. - Antidepressants (SSRIs, SNRIs): possible alteration of sleep architecture. - Caffeine-containing products: may diminish melatonin’s sleep‑promoting effect. - Alcohol: can enhance drowsiness and impair coordination.